Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Current Science Country of Publication: United States NLM ID: 101093791 Publication Model: Electronic Cited Medium: Internet ISSN: 1539-0829 (Electronic) Linking ISSN: 15344827 NLM ISO Abbreviation: Curr Diab Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: Philadelphia, PA : Current Science, c2001-
    • Subject Terms:
      Diabetes Mellitus, Type 2/*epidemiology ; Diabetes Mellitus, Type 2/*prevention & control ; Public Health/*methods ; Public Health/*statistics & numerical data; Health Promotion ; Humans ; Life Style ; Preventive Health Services/statistics & numerical data ; Risk Factors ; United States/epidemiology
    • Abstract:
      Purpose of Review: This article highlights foundational evidence, translation studies, and current research behind type 2 diabetes prevention efforts worldwide, with focus on high-risk populations, and whole-population approaches as catalysts to global prevention.
      Recent Findings: Continued focus on the goals of foundational lifestyle change program trials and their global translations, and the targeting of those at highest risk through both in-person and virtual modes of program delivery, is critical. Whole-population approaches (e.g., socioeconomic policies, healthy food promotion, environmental/systems changes) and awareness raising are essential complements to efforts aimed at high-risk populations. Successful type 2 diabetes prevention strategies are being realized in the USA through the National Diabetes Prevention Program and elsewhere in the world. A multi-tiered approach involving appropriate risk targeting and whole-population efforts is essential to curb the global diabetes epidemic.
    • Comments:
      Comment in: Curr Diab Rep. 2019 Nov 20;19(11):130. (PMID: 31748826)
      Erratum in: Curr Diab Rep. 2020 Jun 27;20(8):36. (PMID: 32591936)
    • References:
      JAMA. 2003 Apr 9;289(14):1833-6. (PMID: 12684363)
      Lancet. 2006 Nov 11;368(9548):1673-9. (PMID: 17098085)
      Eur J Clin Nutr. 2017 Jun;71(6):694-711. (PMID: 27901036)
      Am J Public Health. 2010 Feb;100(2):216-22. (PMID: 20019319)
      Diabetes Care. 2012 Apr;35(4):723-30. (PMID: 22442395)
      Diabetes Care. 1997 Apr;20(4):537-44. (PMID: 9096977)
      BMJ Open. 2017 Aug 21;7(8):e014953. (PMID: 28827235)
      Curr Diab Rep. 2017 Feb;17(2):9. (PMID: 28150162)
      Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75. (PMID: 26377054)
      Diabetes Care. 2007 Oct;30(10):2548-52. (PMID: 17670917)
      BMC Public Health. 2018 Jan 2;18(1):97. (PMID: 29291708)
      Diabetologia. 2011 Feb;54(2):300-7. (PMID: 21046360)
      BMJ. 2011 Nov 28;343:d7163. (PMID: 22123912)
      Lancet Diabetes Endocrinol. 2013 Nov;1(3):191-8. (PMID: 24622367)
      Trials. 2012 Aug 28;13:152. (PMID: 22929458)
      BMJ. 2016 Jan 06;352:h6704. (PMID: 26738745)
      Curr Diab Rep. 2016 Jun;16(6):55. (PMID: 27145778)
      Intern Emerg Med. 2016 Apr;11(3):375-84. (PMID: 26475162)
      Nutrition. 2015 Jun;31(6):787-95. (PMID: 25933484)
      Lancet. 2009 Nov 14;374(9702):1677-86. (PMID: 19878986)
      Diabetologia. 2006 Feb;49(2):289-97. (PMID: 16391903)
      Obes Rev. 2015 May;16(5):362-75. (PMID: 25753170)
      BMC Public Health. 2007 Sep 19;7:249. (PMID: 17877832)
      Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-461. (PMID: 31036503)
      Health Aff (Millwood). 2012 Jan;31(1):67-75. (PMID: 22232096)
      Diabetes Care. 2017 Oct;40(10):1331-1341. (PMID: 28500215)
      N Engl J Med. 2001 May 3;344(18):1343-50. (PMID: 11333990)
      Med Clin North Am. 2011 Mar;95(2):373-84, viii. (PMID: 21281839)
      Diabetes Res Clin Pract. 2018 Aug;142:213-221. (PMID: 29859274)
      Diabetes Res Clin Pract. 2005 Feb;67(2):152-62. (PMID: 15649575)
      N Engl J Med. 2002 Feb 7;346(6):393-403. (PMID: 11832527)
      Prev Chronic Dis. 2015 Apr 30;12:E57. (PMID: 25927605)
      Am J Prev Med. 2018 Aug;55(2):e39-e47. (PMID: 29934016)
      Diabet Med. 2010 Apr;27(4):459-65. (PMID: 20536519)
      Lancet. 2008 May 24;371(9626):1783-9. (PMID: 18502303)
      PLoS Med. 2017 Jun 6;14(6):e1002311. (PMID: 28586351)
      Diabetes Care. 2018 May;41(5):917-928. (PMID: 29567642)
      Diabetes Care. 1999 Apr;22(4):623-34. (PMID: 10189543)
      Anesthesiology. 2011 Nov;115(5):909-11. (PMID: 21934485)
      JAMA Netw Open. 2019 May 3;2(5):e193160. (PMID: 31074808)
      Am J Prev Med. 2013 Apr;44(4 Suppl 4):S346-51. (PMID: 23498297)
      Am J Clin Nutr. 2014 Mar;99(3):454-62. (PMID: 24368435)
      Obes Rev. 2016 Dec;17(12):1198-1217. (PMID: 27484468)
    • Contributed Indexing:
      Keywords: Diabetes policy; Diabetes prevention; Diabetes prevention program; National Diabetes Prevention Program; Obesity; Type 2 diabetes
    • Publication Date:
      Date Created: 20190807 Date Completed: 20200331 Latest Revision: 20200630
    • Publication Date:
      20231215
    • Accession Number:
      PMC6682852
    • Accession Number:
      10.1007/s11892-019-1200-z
    • Accession Number:
      31385061